Amneal Pharmaceuticals, Inc. (AMRX)
Healthcare
Drug Manufacturers - Specialty & Generic
18.30 $
-1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Amneal Pharmaceuticals, Inc. (AMRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.9% of the shares are freely tradable; institutional investors hold 52.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
52.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
44.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
55.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
319Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.68 | 24,519,192 | +71.5 | 03/31/2026 |
| TPG GP A, LLC | 3.86 | 12,328,767 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.55 | 11,324,933 | +0.0 | 03/31/2026 |
| Rubric Capital Management LP | 3.46 | 11,037,589 | -10.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.38 | 7,585,034 | +0.0 | 03/31/2026 |
| State Street Corp | 2.13 | 6,794,702 | +65.3 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 1.78 | 5,690,586 | +1.5 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 1.45 | 4,637,185 | -3.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3.29 | 10,510,837 | +0.0 | 07/28/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.74 | 5,557,806 | +0.1 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.